PolicyBazaar's Parent PB Fintech Grants ₹644 Cr Worth of ESOPs
PB Fintech, the parent company of India's leading online insurance marketplace PolicyBazaar and lending platform Paisabazaar, has announced a substantial grant of Employee Stock Options (ESOPs) to its eligible employees.
Key Details of the ESOP Grant
Parent Company: PB Fintech Ltd.
Total Value: Approximately ₹644 crore (or $72 million).
Number of Options: The company's Nomination and Remuneration Committee approved the grant of 35.11 lakh (3.51 million) stock options.
Scheme: The grant was made under the company's ESOP 2024 plan.
Valuation Basis: The ₹644 crore valuation is based on PB Fintech's current share price of around ₹1,835 per share (at the time of the announcement).
Exercise Price and Vesting: The options are convertible into one equity share each, with an exercise price of approximately ₹1,589.67 per option (a 10% discount to the 90-day volume-weighted average price preceding the grant). The options will vest over a period of up to eight years, with a specific condition: they will only vest if the Volume Weighted Average Price (VWAP) on the vesting date is 150% or higher of the VWAP preceding the grant date.
Purpose: This move is aimed at employee retention and aligning the interests of employees with the long-term value creation and success of the company.
🚀 Other Significant Developments for PB Fintech
In addition to the ESOP grant, the company has announced other important strategic moves:
RBI Approval for Payment Aggregator: PB Pay Private Limited, a wholly-owned subsidiary of PB Fintech, has received the in-principle approval from the Reserve Bank of India (RBI) to operate as an online payment aggregator under the Payment and Settlement Systems Act, 2007. This is a significant step into the digital payments and financial services ecosystem.
Capital Infusion in Healthcare Arm: The PB Fintech board has also approved a substantial investment of ₹696 crore (approximately $80 million) into its subsidiary, PB Healthcare Services Pvt Ltd. This capital infusion is intended to accelerate the growth and enhance operations of its healthcare-focused business.
Financial Context
The ESOP grant comes amid a period of strong financial performance for PB Fintech. In the second quarter of the current fiscal year (Q2 FY26):
Revenue from Operations grew by 20% to ₹1,613 crore compared to the same period in the previous fiscal year.
Net Profit surged by 2.6 times to ₹135 crore.
This comprehensive move—granting ESOPs, receiving a payment aggregator license, and investing heavily in healthcare—shows PB Fintech's strategy to strengthen its core business, diversify into allied financial services, and secure employee commitment for its future growth.